|
WO2021061697A1
|
|
Predicting neonatal complications using genetic variation
|
|
US2021077527A1
|
|
Universal donor selection method to identify nk-cell-donors
|
|
WO2021046341A1
|
|
Computerized screening tool for behavioral health
|
|
WO2021022167A2
|
|
Compositions and methods for diagnosing urinary tract obstruction
|
|
WO2020092531A1
|
|
Factor xiii immunoassay
|
|
WO2020076889A1
|
|
Anticancer rocaglamide derivatives
|
|
SG11202101829UA
|
|
Chimeric oncolytic herpesvirus that stimulate an antitumor immune response
|
|
KR20210025075A
|
|
Compositions and methods for mediating EPS
|
|
KR20210028162A
|
|
Recombinant adeno-associated virus products and methods for the treatment of rhomboid muscle dystrophy type 2A
|
|
WO2020006336A1
|
|
Treatment of cardiovascular calcification using nuclear export inhibitors
|
|
WO2018098229A1
|
|
Apparatus and method for metal-type differentiation
|
|
WO2018094021A1
|
|
Steroid resistance in nephrotic syndrome
|
|
WO2018057889A1
|
|
Tube securing device and method of use
|
|
US2019336332A1
|
|
Treatment of spinal muscular atrophy by inducing heat shock response
|
|
US2018264219A1
|
|
Interactive spacer for respiratory device
|
|
EP3572516A1
|
|
Methods and materials for activating an internal ribosome entry site in exon 5 of the dmd gene
|
|
US2016030114A1
|
|
Medical testing apparatus and method of use
|
